News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
News
Policy
GlaxoSmithKline Sues Partner XenoPort, Inc. Over Marketing Allegations on RLS Drug
February 24, 2012
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
GlaxoSmithKline (NYSE:GSK) is pushing back against drug partner XenoPort (NASDAQ:XNPT) over claims that GSK is not doing enough to sell the restless-leg syndrome treatment they jointly developed.
Twitter
LinkedIn
Facebook
Email
Print
Legal
Europe
GlaxoSmithKline
MORE ON THIS TOPIC
Vaccines
Reformed ACIP Recommends Delaying MMRV Combo Vaccination, Forecasts Changes to Hep B, COVID
September 19, 2025
·
2 min read
·
Tristan Manalac
Rare diseases
Hope for Rare Pediatric Disease Voucher Reignited as House Bill Passes Committee
September 19, 2025
·
2 min read
·
Tristan Manalac
Layoffs
Layoffs From Just 6 Pharmas Could Wipe Out Over 39,000 Jobs
September 18, 2025
·
9 min read
·
Angela Gabriel
PODCAST
What Do AI and Hammers Have in Common?
September 18, 2025
·
1 min read
·
Lori Ellis
